Skip to content

Return of nelfinavir's European license recommended

ICAAC: Incidence of non-AIDS-defining cancers remains higher for HIV-positive individuals despite HAART

ICAAC: Gardasil provides some protection against wide spectrum of cancer-causing HPV

US guidance says that pregnant women should not take nelfinavir

Nelfinavir shows promise as a cancer therapy

Cervical screening for HIV-infected women worldwide is a 'must'

IAS: HPV diversity suggests value of HIV-positive gay men receiving Gardasil

IAS: Incidence of some cancers increasing significantly in HIV-positive individuals

IAS: Aging with HIV - are cancer, heart disease, dementia the new challenges?